About Company

Phrontline Biopharma is dedicated to developing novel ADCs for unmet medical needs in oncology. Our company specializes in optimizing dual targeting in ADC. To mitigate drug resistance, we have developed dual payload platforms to prolong drug response based on several decades of clinical experience of combo chemotherapy. Guided by Science, Phrontline is committed to become a premier international biopharma specialized in delivering frontline therapies.

About Us